Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

Launched by FONDAZIONE IRCCS CA' GRANDA, OSPEDALE MAGGIORE POLICLINICO · Apr 7, 2022

Keywords

ClinConnect Summary

This clinical trial, called the OMPR-Ach/Hy Registry, is focused on collecting important information about patients with two specific conditions: achondroplasia and hypochondroplasia. These are genetic disorders that affect bone growth and can lead to shorter stature and other health issues. The study is currently open for enrollment, meaning they are looking for new participants to join.

To be eligible for this study, you need to have a confirmed diagnosis of either achondroplasia or hypochondroplasia, and you or your legal guardian must be able to give informed consent, which means understanding what the study involves and agreeing to participate. Unfortunately, if you do not have one of these diagnoses or cannot provide consent, you would not be able to join. Participants in the study can expect to share their medical history and receive regular follow-ups, which helps researchers gather valuable data to improve understanding and treatment of these conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed diagnosis of achondroplasia/hypochondroplasia
• • Patients (and/or Parents legal guardian when required) able to provide informed consent
• Exclusion Criteria:
• • Absence of diagnosis of achondroplasia/hypochondroplasia
• • Patients (and/or Parents legal guardian when required) not able to provide informed consent